BRWA
STAB

B. Riley Wealth Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

B. Riley Wealth Advisors’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,651
Closed -$33K – 1106
2020
Q3 		$33K Sell
16,651
-362
-2% -$834 ﹤0.01% 930
2020
Q2 		$44K Hold
17,013
– – ﹤0.01% 845
2020
Q1 		$29K Buy
17,013
+1,150
+7% +$2.35K ﹤0.01% 769
2019
Q4 		$10K Buy
15,863
+275
+2% +$203 ﹤0.01% 833
2019
Q3 		$16K Buy
+15,588
New +$21K ﹤0.01% 804

Other funds holding STAB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

B. Riley Wealth Advisors's STAB Position: Q4 2020 in Review

B. Riley Wealth Advisors sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q4 2020, closing a stake of 16,651 shares — an estimated $33K sold.

B. Riley Wealth Advisors first reported a position in STAB in Q3 2019 and held it in 5 quarters. The position peaked at $44K in Q2 2020. 21 funds tracked by Wall St. Rank hold STAB as of Q4 2020.

  • B. Riley Wealth Advisors reported no remaining Statera Biopharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 16,651 Statera Biopharma, Inc. Common Stock shares in Q4 2020, an estimated $33K.
  • B. Riley Wealth Advisors first reported a position in Statera Biopharma, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Statera Biopharma, Inc. Common Stock position peaked at $44K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2020.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.